MAPT and Alzheimer disease: There are multiple pathways connecting AD with CRCI, including neuroinflammation, oxidative stress, DNA damage, mitochondrial dysfunction, neuronal and synaptic loss, cellular senescence, BDNF signaling, white matter damage, BBB/vascular dysfunction, tau pathology, and TE reactivation, in addition to common genetic risk factors such as APOE4 status.